Biological agent with neuroprotective effect
A technology of neuron protection and biological preparations, which is applied in the field of medicine, can solve problems such as the route of administration and the way of administration have not been well resolved, and achieve the effect of improving symptoms and reducing local inflammatory reactions
Inactive Publication Date: 2015-03-25
SOUTHERN MEDICAL UNIVERSITY
View PDF0 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, issues such as the route of drug administration in the central nervous system, the method of administration, whether the drug can penetrate the blood-brain barrier, and whether neurons can absorb the drug through layers of glial cells have not been well resolved.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0019] 1. Measure the temperature-sensitive hydrogel and activin B according to the proportion, operate on ice, gently pipette and mix well, and prepare preparations with different concentrations. The concentration of activin B in preparations 1 to 4 is 10 ng in sequence / μl, 15ng / μl, 20ng / μl, 25ng / μl.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention discloses a biological agent with the neuroprotective effect. A temperature sensitive hydrogel coats an activin B to obtain a composite biological agent. The activin B has neuroprotective effect, the novel temperature sensitive hydrogel has neuroprotective effect, and functions of inflammation inhibition and slow release; the activin B in the composite biological agent slowly releases in the brain to play drug effect. The biological agent can synergistically inhibit mice corpus striatum dopaminergic neuron injury caused by Mptp, reduce local inflammation reaction, and improve the symptoms of Parkinson's disease from the perspective of behavioristics. The invention provides important medication reference for the clinic treatment of Parkinson's disease and other neurodegeneration diseases.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a biological preparation with neuron protection effect. Background technique [0002] Parkinson's disease (PD) is a common movement disorder among middle-aged and elderly people with progressive degeneration of dopaminergic neurons in the substantia nigra of the midbrain and lack of neurotransmitter dopamine as the main pathological and biochemical basis. Its clinical symptoms mainly manifest as resting tremor, muscle rigidity, and bradykinesia. Recent epidemiological surveys show that the incidence of Parkinson's disease among people over 65 years old in my country is 1.7%, and the average survival period from diagnosis to death is 15 years. The etiology and pathogenesis of Parkinson's disease are very complex and have not been fully clarified so far. All current treatments for Parkinson's disease are symptomatic treatments, and there is no radical cure. Carrying ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K38/18A61K9/06A61K47/32A61P25/16A61P25/00
Inventor 张璐张琳顾晶晶
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com